Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Squat Jump Performance and Chiropractic Ankle Manipulation

14 de junio de 2026 actualizado por: Jeanmarie R. Burke, PhD, Northeast College of Health Sciences

The Effects of Chiropractic Ankle Manipulation on Athletic Performance of College-Aged Recreational Athletes: Randomized Controlled Trial

The goal of this clinical trial is to learn if chiropractic ankle manipulation can improve squat jump performance. It will also learn about the relationship among chiropractic ankle manipulation, ankle range of motion, and squat jump performance. The main questions it aims to answer are:

  • Does chiropractic ankle manipulation increase squat jump height?
  • Is there a relationship among chiropractic ankle manipulation, ankle range of motion, and squat jump performance?

Researchers will compare squat jump performance between subjects who receive chiropractic ankle manipulations with control subjects to see if ankle chiropractic manipulation works to improve squat jump performance.

Participants will:

  • Visit the research laboratory for one testing session to measure ankle range of motion and squat jump performance, before and after their randomly assigned intervention arm
  • Receive either a chiropractic ankle manipulations or rest quietly as the control condition during the testing session.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Estimado)

60

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

    • New York
      • Seneca Falls, New York, Estados Unidos, 13148
        • Reclutamiento
        • Biomechanics Laboratory at Northeast College of Health Sciences
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

Sí

Descripción

Inclusion Criteria

  • age range from 18 to 35 years old; and
  • participating in recreational exercise, three times a week for at least 30 minutes. Recreational exercise includes ball sports (e.g. soccer, basketball, volleyball, etc.), racket sports (e.g. tennis, pickle ball, racket ball, etc.), strength/combat sports (e.g. weight lifting, boxing, martial arts, kickboxing, etc.), endurance sports (running, cycling, rock climbing, etc.), snow/ice sports (downhill or cross-county skiing, snow shoeing, hockey, etc.), interval training (e.g., high-intensity interval training), sprint interval training, repeated sprint training etc.) or moderate-intensity aerobic activities (step classes, dance classes, hiking, etc.)

Exclusion Criteria

  • professional or amateur ranked athlete;
  • participation in water sports (swimming, water aerobics, kayaking, water skiing, etc.) to meet the recreational exercise inclusion criteria
  • acute or chronic musculoskeletal injury / condition of the feet, ankles, knees, and/or hips;
  • acute or chronic musculoskeletal injury / condition of the spine;
  • pregnancy or there is a possibility of pregnancy.
  • any diagnosed medical condition; and
  • any prescribed medications with the exceptions of birth control, anxiety, or attention-deficit/hyperactivity disorder (ADHD) medications.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Chiropractic Ankle Manipulation

LEM - Lower Extremity Manipulation:

Subjects assigned to the LEM Intervention Group will receive a short lever, high velocity, low-amplitude distractive (caudal) thrust directed at the talocrural joint. The treating chiropractor will deliver the LEM to the right ankle then the left ankle. LEM is an adjustment for long axis distraction of the tibiotalar joint with the goal to improve dorsiflexion of the ankle joint.

The lower extremity manipulation (LEM) procedure is a short lever, high velocity, low-amplitude distractive (caudal) thrust directed at the talocrural joint. The treating chiropractor will deliver the LEM to the right ankle then the left ankle. LEM is an adjustment for long axis distraction of the tibiotalar joint with the goal to improve dorsiflexion of the ankle joint.
Otros nombres:
  • Lower Extremity Manipulation
Sin intervención: Control
Subjects assigned to the Control Group will rest quietly, supine (face up), on the chiropractic treatment table for five (5) minutes.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Squat Jump Height
Periodo de tiempo: Baseline on Day 1 to Immediately after Intervention on Day 1

Subjects will be instructed to jump upwards from the starting squat position as high as possible. Subjects will perform 3 to 6 jumps with 3 consecutive jump heights being within 5% of each other to ensure maximum jump height is achieved. There will be a one-minute rest between jumps.

  • Starting position. Subjects will assume the starting squat position with their hips at 90°, knees at 120°, and ankles at 85° as positioned by the PI. An adjustable plyometric jump box will be used to standardize the starting position. Hands will be resting across their chest with the trunk and head positioned straight ahead.
  • Squat Jump: Subjects will be instructed to jump as high as possible and land in a comfortable position. Hands will remain across the chest for the duration of

The Optojump photoelectric cell system (OptoJump) will be used to record jump height. OptoJump demonstrates strong concurrent validity and excellent test-retest reliability for the estimation of vertical jump height

Baseline on Day 1 to Immediately after Intervention on Day 1
Range of Motion of Ankle Dorsiflexion
Periodo de tiempo: Baseline on Day 1 to Immediately after Treatment on Day 1 and at End of Test Session on Day 1

Knee-to-wall ankle dorsiflexion test:

  • Ankle dorsiflexion ROM (distance from wall - cm) is the maximum distance of the big toe from the wall while maintaining contact between the wall and the knee with the heel on the ground.
  • The subject will repeat the Knee-to-wall ankle dorsiflexion test three times at this maximum distance to allow the PI to record three goniometer measurements of ankle dorsiflexion ROM (degrees°).
Baseline on Day 1 to Immediately after Treatment on Day 1 and at End of Test Session on Day 1

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Leg Muscle Power (W/Kg)
Periodo de tiempo: Baseline on Day 1 to Immediately after Intervention on Day 1
Squat Jump Muscle Parameter: The Optojump will calculate an estimate of leg muscle power (W/Kg). The reliability and concurrent validity of OptoJump to measure jump height suggests that the evidence-base biomechanical formula to calculate the estimate of leg muscle power by OptoJump is reliable with face validity.
Baseline on Day 1 to Immediately after Intervention on Day 1
Contraction Velocity of Leg Muscles (mm/s), Force-Velocity Curve
Periodo de tiempo: Baseline on Day 1 to Immediately after Intervention on Day 1

Squat Jump Muscle Parameter: The Gyko inertial sensor system (Gyko) will measure the velocity of the jump to calculate an estimate of the contraction velocity of leg muscles, force-velocity curve.

The reliability and concurrent validity of Gyko to measure jump height and in-turn estimate muscle function parameters is limited in the literature. The control group in the current study will allow us to address concurrent validity and reliability of Gyko to measure jump height. Jump height measured by Optojump is the gold-standard field base device. Comparison of Gyko to Optojump measurements of jump heights will determine concurrent validity of Gyko to estimate jump height. The use of evidence-base biomechanical formulas to calculate an estimate of contraction velocity of leg muscles during SQJ's depends on recording reliable and valid measurements of jump heights; and in turn, establish the reliability and face validity of Gyko to estimate muscle function parameters.

Baseline on Day 1 to Immediately after Intervention on Day 1
Rate of Force Development of Leg Muscles (N/s), Slope of the Force - Velocity Curve
Periodo de tiempo: Baseline on Day 1 to Immediately after Intervention on Day 1
Squat Jump Muscle Parameter: The Gyko inertial sensor system (Gyko) will measure the velocity of the jump to calculate an estimate of the rate of force development of leg muscles, slope of the force - velocity curve The reliability and concurrent validity of Gyko to measure jump height and in-turn estimate muscle function parameters is limited in the literature. The control group in the current study will allow us to address concurrent validity and reliability of Gyko to measure jump height. Jump height measured by Optojump is the gold-standard field base device. Comparison of Gyko to Optojump measurements of jump heights will determine concurrent validity of Gyko to estimate jump height. The use of evidence-base biomechanical formulas to calculate an estimate of the rate of force development of leg muscles during SQJ's depends on recording reliable and valid measurements of jump heights; and in turn, establish the reliability and face validity of Gyko to estimate muscle function.
Baseline on Day 1 to Immediately after Intervention on Day 1

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de junio de 2026

Finalización primaria (Estimado)

1 de mayo de 2027

Finalización del estudio (Estimado)

1 de mayo de 2027

Fechas de registro del estudio

Enviado por primera vez

31 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

7 de junio de 2026

Publicado por primera vez (Actual)

11 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

16 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

14 de junio de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 26-02

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir